About Us
Genomic Data That Drives Innovation
BioPortal: Connecting Data, Researchers, and Discovery
BioPortal is a unique research platform at the Jewish General Hospital (JGH)/Lady Davis Institute in Montreal, built in partnership with the CERC Chair in Genomic Medicine at McGill.
Our Vision
BioPortal provides a vast range of high-quality biological and clinical data to support innovative research. Our platform offers essential resources for understanding both common complex and rare diseases.
Our Mission
BioPortal provides a vast range of high-quality biological and clinical data to support innovative research. Our platform offers essential resources for understanding both common complex and rare diseases.
Our Strategic perspective
Turning Patient Data Into Better Treatments
Our teams will initially collect the health information in electronic medical records and biological samples from 2,500 diabetic patients per year. With artificial intelligence, our researchers will analyze this information to better understand the individual’s genetic risk for disease and its complications, clarify their diagnoses and find better medicines for their clinical conditions.
From Insight to Impact: Advancing Patient Care
Our teams will initially collect the health information in electronic medical records and biological samples from 2,500 diabetic patients per year. With artificial intelligence, our researchers will analyze this information to better understand the individual’s genetic risk for disease and its complications, clarify their diagnoses and find better medicines for their clinical conditions.
From Insight to Impact: Advancing Patient Care
BioPortal will build on the experience gained in designing, building and exploiting the largest single-site COVID-19 biobank in the country, within the framework of the Québec COVID-19 Biobank.
BioPortal will now focus on improving care for diabetes and will then rapidly expand to other common and rare diseases.